Cytogenix (fka CYGX)

[stock_dough]

IMO the 8K is interesting reading however it seems to me much of what transpired is now irrelevant. The following excerpt from the 8K is what will in the long term sustain the company:

CytoGenix, Inc. is a Houston-based biopharmaceutical company that develops and markets innovative products and services based on its proprietary ssDNA expression technology. The company has developed a breakthrough synthetic process for large-scale production of high purity DNA at a fraction of the cost of traditional fermentation methods. CytoGenix currently has one issued US patent and 47 international or US pending patent applications claiming methods and materials in connection with this platform technology (emphasis added).